Publications
Events
Advertise
Subscribe
MyBN
Log In
Search
Menu
Close Navigation
Login
MyBN
Latest News
Resources
Property
Commercial Content
Back to previous menu
Close
Commercial Content
Announcements
Bulls N' Bears
Business Advice
Hearts & Minds
Industry Content
Skyline
Thought Leadership
All Categories
Back to previous menu
Close
All Categories
Resources
Property
Deals
Opinion
Government
Agribusiness
Education
Health
Infrastructure
Oil & Gas
Remuneration
Retail
Small Business
Technology, Innovation & Science
Tourism
Transport & Logistics
Explore All Categories
Data & Insights
Publications
Events
Advertise
Subscribe
Lists
Christopher M Fullerton
Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN
Log In
Christopher M Fullerton
Lists and Charts
Total Shareholder Return
as at 29/02/24
Rank
Company
1 yr
5 yr
860
th
Ironbark Capital
-9%
3%
1124
th
Bill Identity
-27%
1125
th
Forbidden Foods
-27%
1780
th
Paradigm Biopharmaceuticals
-73%
-20%
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
Rank
Company
Revenue
832
nd
Paradigm Biopharmaceuticals
$6.8m
865
th
Ironbark Capital
$4.9m
866
th
DGO Gold
$4.8m
868
th
Bill Identity
$4.7m
869
th
Forbidden Foods
$4.7m
View Full List
1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Show All Lists and Charts
Collapse All Lists and Charts
Related Information
Positions
- Previous
Position
Company
Year
Company's current rank
Non-Executive Director
Paradigm Biopharmaceuticals
-
832
Subscribe today for award-winning, unbiased and trusted journalism
Subscription Options